Ireland
--:--IST
Latest
Clinical Trials in Sweden / NCT05432297
Recruiting Not applicable

Preventive Physical Activity Intervention in Head and Neck Cancer

NCT05432297 · tracked via the Priya Life Science Sweden tracker
Phase
Not applicable
Started
2023-01-02
Last updated
2026-04-23

Condition(s) studied

Head and Neck NeoplasmsPhysical Inactivity

Investigational drug(s) / intervention(s)

Preventive physical exercise

Preventive physical exercise: Daily physical activity depending on daily condition

Study summary

The study includes patients with tumors of the oropharynx, larynx and hypopharynx scheduled to receive radiotherapy with curative intent (+/- chemotherapy). The patients will be randomized into either an intervention group (performing a preventive physical activity protocol before and during radiotherapy) or a control group not performing a specified physical exercise protocol. All patients will be in contact with with a speech language pathologist or a physical therapist weekly during radiotherapy. The study is expected to improve physical function and quality of life during and after oncologic treatment

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Head and neck cancer (tumors of the oropharynx, pharynx, hypopharynx and larynx) * Receiving radiohterapy (+/- chemotherapy) with curative intent Exclusion Criteria: * Surgery due to head and neck cancer * Previous treatment for head and neck cancer * Tracheostomized patients * Inability to perform exercise intervention * Inability to perform part of 6-minute walking test * Inability to independently fill out questionnaires in Swedish * Previous neurologic or neuromuscular disease

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sahlgrenska University Hospital Gothenburg Sweden Recruiting

More Sahlgrenska University Hospital trials in Sweden

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05432297 on ClinicalTrials.gov ↗ ← All trials in Sweden